Clinical Trial Update: LB-100, Carboplatin, Etoposide, and Atezolizumab for the Treatment of Untreated Extensive-Stage Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating LB-100 in combination with carboplatin, etoposide, and atezolizumab for untreated extensive-stage small cell lung cancer; the study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• CARBOPLATIN (Carboplatin)
• Etoposide (Etoposide)
• LB-100 (LB-100)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Extensive Stage Lung Small Cell Carcinoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING